Publication Cover
Amyloid
The Journal of Protein Folding Disorders
Volume 23, 2016 - Issue 1
1,891
Views
12
CrossRef citations to date
0
Altmetric
Original Article

Amyloid persistence in decellularized liver: biochemical and histopathological characterization

, , , , , , , , , , , , , , & show all
Pages 1-7 | Received 21 Aug 2015, Accepted 15 Oct 2015, Published online: 08 Dec 2015

References

  • Pepys MB. Amyloidosis. Annu Rev Med 2006;57:223–41
  • Bellotti V, Chiti F. Amyloidogenesis in its biological environment: challenging a fundamental issue in protein misfolding diseases. Curr Opin Struct Biol 2008;18:771–9
  • Bonsib SM, Plattner SB. Acellular scanning electron microscopy of spicular renal amyloidosis. Ultrastruct Pathol 1986;10:497–504
  • Baptista PM, Siddiqui MM, Lozier G, Rodriguez SR, Atala A, Soker S. The use of whole organ decellularization for the generation of a vascularized liver organoid. Hepatology 2011;53:604–17
  • Guyette JP, Gilpin SE, Charest JM, Tapias LF, Ren X, Ott HC. Perfusion decellularization of whole organs. Nat Protoc 2014;9:1451–68
  • Uygun BE, Soto-Gutierrez A, Yagi H, Izamis ML, Guzzardi MA, Shulman C, Milwid J, et al. Organ reengineering through development of a transplantable recellularized liver graft using decellularized liver matrix. Nat Med 2010;16:814–20
  • Mazza G, Rombouts K, Rennie Hall A, Urbani L, Vinh Luong T, Al-Akkad W, Longato L, et al. Decellularized human liver as a natural 3D-scaffold for liver bioengineering and transplantation. Sci Rep 2015;5:13079
  • Badylak SF, Taylor D, Uygun K. Whole-organ tissue engineering: decellularization and recellularization of three-dimensional matrix scaffolds. Annu Rev Biomed Eng 2011;13:27–53
  • Maghsoudlou P, Georgiades F, Tyraskis A, Totonelli G, Loukogeorgakis SP, Orlando G, Shangaris P, et al. Preservation of micro-architecture and angiogenic potential in a pulmonary acellular matrix obtained using intermittent intra-tracheal flow of detergent enzymatic treatment. Biomaterials 2013;34:6638–48
  • Totonelli G, Maghsoudlou P, Garriboli M, Riegler J, Orlando G, Burns AJ, Sebire NJ, et al. A rat decellularized small bowel scaffold that preserves villus-crypt architecture for intestinal regeneration. Biomaterials 2012;33:3401–10
  • Elliott MJ, De Coppi P, Speggiorin S, Roebuck D, Butler CR, Samuel E, Crowley C, et al. Stem-cell-based, tissue engineered tracheal replacement in a child: a 2-year follow-up study. Lancet 2012;380:994–1000
  • Simons JP, Al-Shawi R, Ellmerich S, Speck I, Aslam S, Hutchinson WL, Mangione PP, et al. Pathogenetic mechanisms of amyloid A amyloidosis. Proc Natl Acad Sci USA 2013;110:16115–20
  • Sipe J. Revised nomenclature for serum amyloid A (SAA). Nomenclature Committee of the International Society of Amyloidosis. Part 2. Amyloid 1999;6:67–70
  • Hoffman JS, Ericsson LH, Eriksen N, Walsh KA, Benditt EP. Murine tissue amyloid protein AA. NH2-terminal sequence identity with only one of two serum amyloid protein (ApoSAA) gene products. J Exp Med 1984;159:641–6
  • Puchtler H, Waldrop FS, Meloan SN. A review of light, polarization and fluorescence microscopic methods for amyloid. Appl Pathol 1985;3:5–17
  • Axelrad MA, Kisilevsky R, Willmer J, Chen SJ, Skinner M. Further characterization of amyloid-enhancing factor. Lab Invest 1982;47:139–46
  • Hawkins PN, Wootton R, Pepys MB. Metabolic studies of radioiodinated serum amyloid P component in normal subjects and patients with systemic amyloidosis. J Clin Invest 1990;86:1862–9
  • Botto M, Hawkins PN, Bickerstaff MC, Herbert J, Bygrave AE, McBride A, Hutchinson WL, et al. Amyloid deposition is delayed in mice with targeted deletion of the serum amyloid P component gene. Nat Med 1997;3:855–9
  • Hawkins PN, Myers MJ, Epenetos AA, Caspi D, Pepys MB. Specific localization and imaging of amyloid deposits in vivo using 123I-labeled serum amyloid P component. J Exp Med 1988;167:903–13
  • Eriksen N, Ericsson LH, Pearsall N, Lagunoff D, Benditt EP. Mouse amyloid protein AA: homology with nonimmunoglobulin protein of human and monkey amyloid substance. Proc Natl Acad Sci USA 1976;73:964–7
  • Janigan DT. Experimental amyloidosis: Studies with a modified casein method, casein hydrolysate and gelatin. Am J Pathol 1965;47:159–71
  • Garcia CA, Abell-Aleff PC, Gamb SI, Miller DV. Ultrastructural analysis of amyloidoma. Ultrastruct Pathol 2009;33:123–7
  • Baltz ML, Caspi D, Hind CRK, Feinstein A, Pepys MB. Isolation and characterization of amyloid enhancing factor (AEF). In: Glenner GG, Osserman EF, Benditt EP, Calkins E, Cohen AS, Zucker-Franklin D, eds. Amyloidosis. New York: Plenum Press; 1986:115–21
  • Herling TW, Garcia GA, Michaels TC, Grentz W, Dean J, Shimanovich U, Gang H, et al. Force generation by the growth of amyloid aggregates. Proc Natl Acad Sci USA 2015;112:9524–9